About Us
We are developing potentially best in class therapies for patients living with severe autoimmune diseases. Our lead antibody, Claseprubart (DNTH103), is purposefully engineered with extended half-life, improved potency, and high selectivity for only the active...
Dianthus Therapeutics
12 days ago